Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Max Planck reports cysteine-containing compounds as MMP inhibitors

Jan. 12, 1999

Shionogi patents water-soluble inhibitors of human sPLA2

Jan. 12, 1999

Important end-of-year approval by FDA: Celebrex for arthritis

Jan. 4, 1999

New COX-2 inhibitor series patented by Searle

Jan. 4, 1999

Gene transfer of plasmid DNA encoding TGF-beta for suppressing inflammation in arthritis

Dec. 30, 1998

SmithKline Beecham announces setback in RA trials

Dec. 30, 1998

Cytokine production inhibitors for inflammatory disorders in development at Ortho-McNeil

Dec. 30, 1998

Synvisc cleared for marketing in several Pacific Rim countries

Dec. 29, 1998

Phase II trial results for Immune Response's therapeutic RA vaccine published

Dec. 29, 1998

Combination of PGE1 + rolipram or pentoxifylline shows potential for RA

Dec. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...